Snag a bestselling car vac at its lowest price this year, plus more of today's best deals
Adidas: Get up to 40% off sale shoes and apparel.
Coach Outlet: Save up to 70% on sale styles.
Cozy Earth: Get up to 30% off Oprah-approved bedding and pajamas during the Mother's Day Sale.
Everlane: Get up to 75% off sale styles.
Kate Spade Outlet: Get up to 75% off everything.
Loft: Take 40% off your entire purchase.
Nordstrom: Shop thousands of sale items for up to 80% off.
Nordstrom Rack: Save up to 70% on thousands of new markdowns.
Old Navy: Score 30-50% off almost everything on the site.
Spanx: Get up to 40% off select AirEssentials sale items, and up to 70% off sale items.
Sur La Table: Save up to 60% on top brands like Staub, Le Creuset and more.
Target: Snag marked-down Easter accessories and get up to 40% off select vacuums.
Walmart: Shop rollbacks and flash deals of up to 80% off.
Wayfair: Stock up on patio tables and chairs for up to 50% off during the Big Outdoor Sale.
If you have Amazon Prime, you'll get free shipping, of course. Not yet a member? No problem. You can sign up for your free 30-day trial here. (And by the way, those without Prime still get free shipping on orders of $35 or more.)
The reviews quoted above reflect the most recent versions at the time of publication.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Wire
2 hours ago
- Business Wire
Theraclion Growth Up in S1 2025
MALAKOFF, France--(BUSINESS WIRE)--Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), an innovative company developing Sonovein®, a robotic platform for non-invasive High-Intensity Focused Ultrasound (HIFU) varicose vein treatment, reviews its business for S1 2025. Sales of consumables (recurring revenue) up 30% compared to 2024 New treatment centers opened in Bulgaria and Spain Appointment of a new business manager and acceleration of commercial activities On-schedule completion of the follow-up period for the pivotal FDA clinical trial Martin Deterre, CEO of Theraclion, states: "In early 2025, Theraclion stepped up Sonovein's activity. In June, the final 12-month follow-ups for patients in the pivotal FDA-approved clinical trial were completed on-schedule. We are now awaiting the final results, which we expect to publish in September. Theraclion has also entered a business development phase: building a sales and marketing team, opening two new Sonovein treatment centers, and achieving significant growth in recurring revenue — all of which promise the achievement of our ambitious goals." Commercial activity acceleration As part of its business development, Theraclion is actively building its sales and marketing team. In May 2025, Thibault Le Normand joined the company as Chief Business Officer to boost sales in the Middle East and product placements (PPUs) of Sonovein in Europe. With over a decade of experience in international development of medical devices, Thibault Le Normand brings valuable expertise to this strategic growth phase. At the same time, the technological credibility and clinical maturity of Sonovein have been further demonstrated by the publication of new scientific articles as well as by over a dozen presentations at major international congresses by renowned physicians using the device. Sonovein's international profile has also increased through Theraclion's participation in congresses, such as Vein in Venice (April, Venice), Venous Symposium (May, New York), and the European Venous Forum (June, Krakow). This outreach effort was supported by the launch of a new product identity and a new website, giving Sonovein a new brand image that reflects innovation, clinical excellence, and ambition. In addition, two new product placement (PPU) contracts for Sonovein have been signed in Bulgaria and Spain, stepping up Theraclion's presence in Europe and expanding the installed base of the technology. Revenue for S1 2025 Theraclion's revenue for S1 2025 was €835K, up 89% compared to 2024 (€442K) (prior to the non-recurring adjustment of €680K related to the cancellation of Echopulse system sales in 2024). Consumables, which include recurring revenues from PPUs, was up 30% compared to S1 2024. Service revenues were up 232% over the same period. This strong momentum is a key indicator of increasing use of Sonovein by treatment centers and reflects the technology's sustained traction in the field. Combined, consumables and services — representing recurring revenue — was up 57% compared to 2024. Progress of the pivotal FDA clinical trial In the USA, the pivotal FDA-approved study for SONOVEIN® reached a major milestone in June 2025 with the on-schedule completion of the 12-month post-treatment patient follow-ups. Data analysis is currently underway, with results expected in September. Submission of the marketing authorization application to the FDA is planned for Fall 2025, with potential approval estimated for Q2 2026, subject to the FDA's processing time. This progress marks a critical strategic milestone in the work to access the world's largest market for venous disease treatment. Next financial publication: Theraclion will publish its interim financial results on October 29, 2025. About Theraclion Theraclion is a French MedTech company committed to developing a non-invasive alternative to surgery through the innovative use of focused ultrasound. High Intensity Focused Ultrasound (HIFU) does not require incisions or an operating room, leaves no scars, and patients can immediately resume their routines. HIFU treatment concentrates therapeutic ultrasounds on an internal focal point from outside the body. Theraclion is developing SONOVEIN®, a CE-marked, a robotic platform for HIFU varicose vein treatment, which could replace millions of surgical procedures every year. In the USA, SONOVEIN® is an investigational device limited to investigational use; it is not available for sale in the USA. Based in Malakoff (Paris), the Theraclion team comprises some 30 people, most of them involved in technological and clinical development. Theraclion is listed on Euronext Growth Paris Eligible for the PEA-PME scheme Mnemonic: ALTHE - ISIN code: FR0010120402 LEI: 9695007X7HA7A1GCYD29
Yahoo
2 hours ago
- Yahoo
Puma Surprises Market With Early Q2 Results, Slashes Guidance for 2025
German sportswear brand Puma surprised local markets after it released preliminary second-quarter results that were below expectations and then slashed its outlook for the full year. The news sent Puma's stock into a dive, closing Friday down 16 percent to 20.70 euros. More from WWD KidSuper to Open Rooftop Soccer Field in Brooklyn Adidas Is Bringing Bold Animal Prints to Another One of Its Classic Sneaker Models Bad Bunny Goes on 'Stephen Colbert' Wearing Tan Suede Adidas Wales Bonner Sneakers 'Amid ongoing volatile geopolitical and macroeconomic volatility, Puma anticipates that both sector-wide and company-specific challenges will continue to significantly impact performance in 2025,' the company said in a statement issued late Thursday evening. Between April and June, Puma sales fell by 2 percent, in currency adjusted terms, to 1.94 billion euros. This meant that over the first half of 2025, the brand's sales decreased by 1 percent, in currency adjusted terms, compared to the same period last year. So far in 2025, Puma sales have totaled 4.02 billion euros. Puma also made deep cuts to its guidance for the rest of the year. The German brand now expects sales to drop by low-double digits over the whole year and also issued a profit warning. Previously the company had been much more upbeat, predicting low growth and a positive EBIT — earnings before income and taxes — of somewhere between 445 million and 525 million euros. Now it expects a loss. In Friday morning trading in Germany, Puma shares lost almost 20 percent in value. That comes on top of losses in March after the company's initial profit warning, from which Puma shares have not yet recovered. A combination of factors is to blame for the turnaround in guidance, Puma's chief financial officer Markus Neubrand told journalists at a hastily arranged press conference to discuss the preliminary second-quarter results. Puma was not doing well at wholesale, he said, with North America in particular presenting the brand problems. That market makes up around one-fifth of Puma's sales worldwide. Tariffs being imposed by the U.S. government under President Donald Trump were also an issue for Puma, despite the company changing sourcing to suit and bringing extra stock into the U.S. ahead of tariffs, Neubrand added. 'The impact from U.S. tariffs were previously excluded from our guidance,' Neubrand explained. 'We also factored in what we've seen in the second quarter and the gross profit margin is also behind expectations. That combination [of factors] is the key explanation for the change.' Puma saw the biggest drop in sales in North America: These slumped 9.1 percent, in currency adjusted terms, over the second quarter. In Puma's home market of Europe, sales fell 3.9 percent. They dropped by the same percentage in Greater China. In the Asia-Pacific region, Puma sales slipped 2.4 percent, in currency adjusted terms. The only markets to see growth were smaller ones, with Latin American sales rising 16.1 percent and Eastern Europe, the Middle East and Africa totting up a small sales boost of half a percentage point. The company was also holding too much inventory, the Puma executive conceded, and is having issues selling at full price. In terms of product categories, sales of Puma footwear grew 5.1 percent, in currency adjusted terms. Apparel and accessories fell by 10.7 percent and 6.4 percent, respectively. Puma had expected to capitalize on the so-called 'low profile' trend with its range of Speedcat products. Although these were doing well in fashion-forward Asian markets and in trendy metropolitan stores elsewhere, Speedcat had not resonated with customers more generally and sales 'are behind expectations,' Neubrand noted. Also present at the press conference was the company's new chief executive officer, Arthur Hoeld, who previously spent 26 years at Puma's much larger, local competitor Adidas. Hoeld started the job on July 1, taking the place of Arne Freundt, who led Puma for around two-and-a-half years. Hoeld held a wide variety of roles at Adidas, including in global sales, brand strategy and regional management. Analysts have suggested that in such difficult market circumstances, Hoeld may have wanted a 'clean slate' before he initiates his own strategy, which may have been another reason for the unexpectedly drastic cut in Puma's guidance. Hoeld himself wouldn't be drawn in detail on where he might take the company next. 'We need to ask ourselves some tough questions,' Hoeld told media on Friday morning. 'I am aware of the disappointment…I do recognize we have some very immediate operational challenges.' But, he added, he'd only been in the top job for three weeks and was still evaluating everything. He promised he would come back to investors, analysts and media with a more fully formed strategy by October. Key areas for that strategy would likely include 'distribution mix, the quality of our distribution, our brand storytelling, our strength in archives and innovation,' Hoeld said. 'These are the things we will investigate to bring our brand forward in the future.' One thing Hoeld was clear on: The strategy put in place by his predecessor, which included big spending on a worldwide marketing campaign, would be discontinued. 'The future starts now,' Hoeld said, adding that he didn't want to dwell on any past mistakes at Puma. The rest of 2025 would be a 'reset' for the brand and then 2026 would be a 'transitional year,' Hoeld said. On Friday morning, market analysts from the likes of Deutsche Bank, JP Morgan and UBS expressed surprise at the new, negative guidance. Several analysts suggested that Hoeld had a tough job ahead of him. Puma was suffering from increased competition in its sector, cash flow issues and high net debt and seemed to have been slow coming to market with some trend-driven products, the analysts said. Best of WWD All the Retailers That Nike Left and Then Went Back Mikey Madison's Elegant Red Carpet Shoe Style [PHOTOS] Julia Fox's Sleekest and Boldest Shoe Looks Over the Years [Photos]
Yahoo
3 hours ago
- Yahoo
Hot weather boosted retail sales in June
Retail sales rose in June as the hot weather boosted fuel and supermarket sales, according to official data. Sales volumes increased by 0.9% in the month, the Office for National Statistics (ONS) said. Supermarkets reported people buying more drinks, while fuel sales were up as consumers "ventured out and about in the sunshine", the ONS said. But it said sales had fallen by 2.8% in May, which was more than it had previously estimated. After May's fall in sales, a rebound in June had been expected, but the rise was lower than many economists had forecast. Ruth Gregory, deputy chief UK economist at Capital Economics, called June's sales increase "disappointingly small". The monthly retail sales numbers have been up and down lately, reflecting weather patterns and a late Easter. But overall, the rise in retail spending has lost momentum, with sales up just 0.2% between April and June compared with the previous three months. That ties in with a separate survey from researchers Gfk which suggests that consumer confidence is weaker than a year ago, and supports economists' views that next month's figures on economic growth will show it was lacklustre in the second quarter of this year. Sales in food stores were up 0.7% in June, the ONS said, while fuel sales rose 2.8%. "The warm weather in June helped to brighten sales, with supermarket retailers reporting stronger trading and an increase in drink purchases," said ONS senior statistician Hannah Finselbach. "It was also a good month for fuel sales as consumers ventured out and about in the sunshine." The Met Office said that England had its warmest June on record, and the second warmest for the UK as a whole, following two heatwaves. Sales at non-food stores rose, the ONS said, with clothing benefiting from promotions and the good weather. This was partially offset by a fall in sales of household goods such as furniture. Jacqueline Windsor, head of retail at PwC UK, said the rebound in sales at supermarkets and fashion retailers was down to shoppers entertaining at home and refreshing their wardrobes. "However, England's warmest June on record also discouraged shoppers from visiting high streets, with footfall declining and online retail sales penetration increasing," she said.
